Global Stents Market Expected To Be Worth US$ 16.5 Billion By 2022


No comments posted yet


Slide 1

Global Stents Market Expected To Be Worth US$ 16.5 Billion By 2022 Market Research Engine has published a new report titled as “Stents Market By Material Analysis (Metallic Biomaterials, Polymers Biomaterials, Natural Biomaterials); By Type Analysis (Coronary Stents, Peripheral Stents, Stent-Related Implants) and By Regional Analysis – Global Forecast by 2016 - 2022” A stent is a small and tiny wire web like tube that a special medical practitioner implants in the body of the patient in order to restore blood flow and support the vessel wall. Stents help to keep the coronary arteries open in order to decrease the rate of a heart attack. A stent reinstates the blood flow and flow of other fluids, based on where the stent is placed. One of the significant causes behind growing cardiovascular conditions is getting habitual to unhealthy lifestyle. Evolving way of life, for example, smoking, physical inactivity, and irregular eating habits hamper the health of the heart. These conditions are prompting probability of hypertension, stoutness, and blockages in supply routes. Thus, aging of population is another element that is driving the development of these items at a critical rate. The use of latest trends in medical field, for example, scaffolds, Bioresorbable stents, bifurcation stent, and biodegradable polymer with an appropriation of more up to date systems and negligibly intrusive strategies are inclining in this industry. These items are optional for bypass surgery. What's more, when utilized as a part of insignificantly obtrusive methods, they offer certain points of interest over traditional surgeries, for example, less recovery time, shorter scars, less physical injury and less danger of infection and less bleeding. The Global Stents Market is expected to exceed more than US$ 16.6 Billion by 2022 at a CAGR of 9.5% in the given forecast period. You Can Browse Full Report: market-report The major driving factors of Global Stents Market are as follows: Growing ageing population and rising prevalence of chronic diseases New developing technological advancements in the field of stents Development of healthcare infrastructure in developing countries Enhanced insurance and repayment The restraining factors of Global Stents Market are as follows: High cost of treatment related with stent implants Strict approval process for stents Availability of optional treatment method The Global Stents Market is segmented on the lines of its material, type and regional. Based on material segmentation it covers metallic biomaterials, polymers biomaterials, natural biomaterials. Based on type segmentation it covers coronary stents, peripheral stents,

Slide 2

stent-related implants, The Global Stents Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries. This report provides: An overview of the global market for Global Stents Market and related technologies. Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022. Identifications of new market opportunities and targeted promotional plans for Global Stents Market. Discussion of research and development, and the demand for new products and new applications. Comprehensive company profiles of major players in the industry. REPORT SCOPE: The scope of the report includes a detailed study of global and regional markets on Global Stents Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp., C. R. Bard, Inc, Elixir Medical Corp., Medtronic plc, Microport Scientific Corp., Stentys S.A., Terumo Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. The Global Stents Market has been segmented as below: By Material Analysis: Metallic Biomaterials Polymers Biomaterials Natural Biomaterials By Type Analysis: Coronary Stents Drug-Eluting Stents (DES) Bare-Metal Coronary Stents Bioabsorbable Stents Peripheral Stents Iliac Femoral-Popliteal

Slide 3

Renal Carotid Stent-Related Implants Synthetic Grafts Vena Cava Filters By Regional Analysis: North America Europe Asia-Pacific Rest of the World Request Sample Report: report Table of Contents INTRODUCTION EXECUTIVE SUMMARY MARKET OVERVIEW WORLD STENTS MARKET, BY PRODUCT WORLD STENTS MARKET, BY BIOMATERIAL WORLD STENTS MARKET, BY GEOGRAPHY COMPANY PROFILES Abbott Laboratories B. Braun Melsungen AG Biotronik SE & Co. KG Boston Scientific Corporation C. R. Bard, Inc. Elixir Medical Corporation Medtronic plc Microport Scientific Corporation

Slide 4

Stentys S.A. Terumo Corporation Media Contact Company Name: Market Research Engine Contact Person: John Bay Email: Phone: +1-855-984-1862 Country: United States Website:

Summary: The Global Stents Market is expected to exceed more than US$ 16.6 Billion by 2022 at a CAGR of 9.5% in the given forecast period.

Tags: global stents market